Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions

E-ISSN： 2212-3911|7|1|76-85

ISSN： 1574-8863

Source： Current Drug Safety, Vol.7, Iss.1, 2012-02, pp. : 76-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension

By Riccioni Graziano

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 700-710

Springer Publishing Company

Access to resources Recommend Favorite

Safety and Efficacy of Green Foliage in the Treatment of Fungal Infections and Associated Clinical Conditions

Current Drug Safety, Vol. 8, Iss. 4, 2013-09 ,pp. : 270-277

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W. Trenkwalder Peter Hollanders Geert Zhao Yanxing Liao Weichi

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension

By Chrysant Steven G. Murray Alexander V. Hoppe Uta C. Dattani Dan Patel Samir Ritter Shannon Zhang Jack

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2841-2849

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

By Chrysant Steven G. Murray Alexander V. Hoppe Uta C. Dattani Dan Patel Samir Hsu Huang Zhang Jack

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1039-1047

Informa Healthcare

Access to resources Recommend Favorite